Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
Rutgers, The State University of New Jersey · Moffitt Cancer Center · +18 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,211
total citations
- FWCI
- 84.89
- Percentile
- 100%
- References
- 47
Citations per year
Authors
18Topics & keywords
Topics
Keywords
- Merkel cell carcinoma
- Merkel cell polyomavirus
- Medicine
- Avelumab
- Response Evaluation Criteria in Solid Tumors
- Internal medicine
- Oncology
- Chemotherapy
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.